VTOL Form 144 Filed for 5,643-Share Sale via Raymond James

Rhea-AI Filing Summary

Bristow Group Inc. (VTOL) Form 144 reports a proposed sale of 5,643 shares of common stock through Raymond James & Associates with an aggregate market value of $215,330.93, with an approximate sale date of 08/07/2025. The filing lists 28,775,000 shares outstanding.

The securities were acquired on 06/22/2019 via an open market purchase and were paid for in purchase. The filer states there were no securities sold in the past three months and includes the standard Rule 144 representation that the signer is not aware of undisclosed material adverse information.

Positive

• Filing provides full Rule 144 details: broker, share count, aggregate value, acquisition date and sale date are all disclosed
• No securities sold in the past three months as reported on the form

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice disclosing a proposed sale of 5,643 shares; no recent sales reported.

The filing provides the required Rule 144 disclosure elements: broker name, number of shares, aggregate market value, acquisition date and method, and an approximate sale date. It documents that the shares were acquired in the open market on 06/22/2019 and that no sales occurred in the prior three months. From an investor-information standpoint this is a procedural compliance filing rather than a material corporate development.

Corporate Governance Expert

TL;DR: Disclosure appears complete for a Form 144; no indication of insider relationship or material new facts in the filing.

The form includes the standard signature representation about material adverse information and details the purchase and planned sale mechanics via Raymond James. The filing does not specify any relationship to the issuer within the provided tables. As presented, it is a compliance disclosure with no additional governance actions or departures reported.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	5643	215330.93	28775000	08/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/22/2019	Open Market Purchase	Open Market Purchase			5643	06/22/2019	Purchase

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VTOL Form 144 disclose?

The form discloses a proposed sale of 5,643 common shares of Bristow Group Inc. with an aggregate market value of $215,330.93 via Raymond James, approx sale date 08/07/2025.

When and how were the shares being sold on VTOL acquired?

The shares were acquired on 06/22/2019 by open market purchase, and the filing notes the payment was a purchase.

Does the Form 144 report any securities sold in the prior three months for VTOL?

The filing states "Nothing to Report" under securities sold during the past three months.

Which broker is handling the proposed sale for VTOL shares?

The broker listed is Raymond James & Associates, 880 Carillon Parkway, St. Petersburg, FL 33716.

What representation does the filer make about material information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.